Published in J Leukoc Biol on May 01, 1988
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev (2009) 3.65
Phosphatidic acid as a second messenger in human polymorphonuclear leukocytes. Effects on activation of NADPH oxidase. J Clin Invest (1991) 1.10
Effects of adhesins from mannose-resistant Escherichia coli on mediator release from human lymphocytes, monocytes, and basophils and from polymorphonuclear granulocytes. Infect Immun (1990) 0.86
Regulation of surface expression of the granulocyte/macrophage colony-stimulating factor receptor in normal human myeloid cells. Proc Natl Acad Sci U S A (1990) 0.83
Modulation of neutrophil superoxide response and intracellular diacylglyceride levels by the bacterial pigment pyocyanin. Infect Immun (1997) 0.81
NPC 15669-modulated human polymorphonuclear neutrophil functional responsiveness: effects on receptor-coupled signal transduction. Br J Pharmacol (1995) 0.76
Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness. J Pharmacol Exp Ther (1990) 2.89
Inhibition of delayed-type contact hypersensitivity in mice deficient in both E-selectin and P-selectin. Blood (1996) 1.33
Biologic effects of an interleukin-1 receptor antagonist protein on interleukin-1-stimulated cartilage erosion and chondrocyte responsiveness. Arthritis Rheum (1991) 1.00
Postreceptor events associated with human neutrophil activation by interleukin-8. J Leukoc Biol (1992) 0.90
Activation of cytotoxic T cells and effector cells in experimental autoimmune thyroiditis by shared determinants of mouse and human thyroglobulins. Clin Immunol Immunopathol (1986) 0.90
Recombinant human interleukin-1 alpha and recombinant human interleukin-1 beta stimulate cartilage matrix degradation and inhibit glycosaminoglycan synthesis. Inflammation (1989) 0.90
Transmembrane signaling in human polymorphonuclear neutrophils: 15(S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid modulates receptor agonist-triggered cell activation. Proc Natl Acad Sci U S A (1993) 0.89
Human polymorphonuclear neutrophil activation with arachidonic acid. Br J Pharmacol (1987) 0.89
Acceleration and increased severity of collagen-induced arthritis in P-selectin mutant mice. J Immunol (1999) 0.88
U-73122: a potent inhibitor of human polymorphonuclear neutrophil adhesion on biological surfaces and adhesion-related effector functions. J Pharmacol Exp Ther (1996) 0.87
Human neutrophil activation with interleukin-1. A role for intracellular calcium and arachidonic acid lipoxygenation. Biochem Pharmacol (1987) 0.86
Function and stimulus-specific effects of phorbol 12-myristate 13-acetate on human polymorphonuclear neutrophils: autoregulatory role for protein kinase C in signal transduction. Inflammation (1988) 0.81
Effects of a protein kinase C inhibitor, K-252a, on human polymorphonuclear neutrophil responsiveness. Biochem Biophys Res Commun (1988) 0.81
Platelet-derived growth factor potentiates cellular responses of articular chondrocytes to interleukin-1. Arthritis Rheum (1991) 0.80
Recombinant human granulocyte-macrophage colony-stimulating factor induces granule exocytosis from human polymorphonuclear neutrophils. Inflammation (1990) 0.80
Preclinical evaluation of anti-inflammatory activities of the novel pyrrolopyrimidine PNU-142731A, a potential treatment for asthma. J Pharmacol Exp Ther (1999) 0.79
Arachidonic acid and 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid modulate human polymorphonuclear neutrophil activation by monocyte derived neutrophil activating factor. Biochem Biophys Res Commun (1987) 0.79
ICAM-1 mediates leukocyte-endothelium adhesive interactions in the reversed passive Arthus reaction. J Leukoc Biol (1996) 0.77
NPC 15669-modulated human polymorphonuclear neutrophil functional responsiveness: effects on receptor-coupled signal transduction. Br J Pharmacol (1995) 0.76
Induction of neutral proteinase and prostanoid production in bovine nasal chondrocytes by interleukin-1 and tumor necrosis factor alpha: modulation of these cellular responses by interleukin-6 and platelet-derived growth factor. Clin Immunol Immunopathol (1992) 0.75
Requirement for cell-bound proteases in the mechanism of human neutrophil activation with various stimuli. Inflammation (1986) 0.75